Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AHRQ releases Making Health Care Safer II report

The Agency for Healthcare Research and Quality (AHRQ) has released a new report, Making Health Care Safer II, which identifies the top 10, evidence-based patient safety strategies available to clinicians.

6 Mar 2013

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

In Africa and Thailand, communities that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study presented this week at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

6 Mar 2013

National Jewish Health receives U.S. patent for POPG and related compounds

Dennis Voelker, PhD, professor of medicine at National Jewish Health, has been awarded a U.S. patent (#8,367,643) for various lipids and related compounds that can inhibit inflammation and infection in the lungs, especially those caused by influenza and respiratory syncytial virus (RSV).

5 Mar 2013

Increased pneumonia rates after Japan earthquake

Significantly increased rates of pneumonia and related deaths were seen after the 2011 Earthquake and Tsunami in Tohoku, Japan, report researchers.

5 Mar 2013

Nursing home patients with pneumonia may need viral screening

Viral testing should be carried out among all older individuals who have been admitted to hospital for nursing home-acquired pneumonia, recommend researchers.

5 Mar 2013

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).

5 Mar 2013

GP consultations: an interview with Associate Professor Helena Britt, University of Sydney

Well it hasn’t varied at all over the last 15 years, which I find pretty amazing because we’ve been through a lot of changes in general practice. Yet, the average length of consultation, as measured from a start to finish time, in a sample of 40,000 consultations in Australia in a year, shows that the average is 15 minutes and the median is 13 minutes.

4 Mar 2013

Clothing closely linked to peak performance for skiers

The sport of cross-country skiing has always been preoccupied with its skis and waxing. Research now demonstrates that to shave off those extra hundredths of a second, competitive skiers should pay more attention to their clothing.

3 Mar 2013

Significant link between defective viruses and increased rate of transmission of major disease

Defective viruses, thought for decades to be essentially garbage unrelated to the transmission of normal viruses, now appear able to play an important role in the spread of disease, new research by UCLA life scientists indicates.

2 Mar 2013

Combination of two environmental factors contributes to schizophrenia

The interplay between an infection during pregnancy and stress in puberty plays a key role in the development of schizophrenia, as behaviourists from ETH Zurich demonstrate in a mouse model. However, there is no need to panic.

2 Mar 2013

India needs political leadership, resources to ensure children's right to health

"India is making positive strides in reducing child mortality through new policies and ambitious programs, but preventing the deaths of millions of children remains one of the country's greatest challenges," health expert and blogger John Butler writes in the Wall Street Journals "India Real Time" blog, noting, "Roughly 1.7 million children under five years old die every year in India, says UNICEF, representing more than a fifth of all child deaths worldwide."

2 Mar 2013

Influenza vaccine linked to narcolepsy in children in England

Researchers have found an increased risk for narcolepsy in children who received the swine flu vaccination in England.

1 Mar 2013

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.

1 Mar 2013

U.N.'s assertion of immunity in cholera outbreak is morally, legally 'right' decision

"When U.N. Secretary-General Ban Ki-moon invoked diplomatic immunity last week for peacekeepers who unwittingly caused the cholera outbreak that killed nearly 8,000 Haitians, his decision looked cold-hearted," but "sympathy for Haitians should not mask the necessity of the secretary-general's decision," Boston Globe correspondent Juliette Kayyem writes in an opinion piece in the newspaper.

1 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Steroids may reduce length of hospital stay in patients with pneumonia

Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care. That's the finding of a Mayo Clinic analysis of eight randomized-controlled clinical trials involving more than 1,100 patients.

1 Mar 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AHRQ releases Making Health Care Safer II report

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

National Jewish Health receives U.S. patent for POPG and related compounds

Increased pneumonia rates after Japan earthquake

Nursing home patients with pneumonia may need viral screening

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

GP consultations: an interview with Associate Professor Helena Britt, University of Sydney

Clothing closely linked to peak performance for skiers

Significant link between defective viruses and increased rate of transmission of major disease

Combination of two environmental factors contributes to schizophrenia

India needs political leadership, resources to ensure children's right to health

Influenza vaccine linked to narcolepsy in children in England

Amoxicillin effectiveness: an interview with Prof Paul Little, University of Southampton

U.N.'s assertion of immunity in cholera outbreak is morally, legally 'right' decision

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Steroids may reduce length of hospital stay in patients with pneumonia

Excess of vitamin D during pregnancy can increase risk of food allergy in children

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

Inviragen to initiate second stage of DENVax Phase 2 study in dengue

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in